Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting
Viruses · 23.07.2023 · 15 (7) · 1612
DOI: 10.3390/v15071612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 23.07.2023. Verfasst von Paolo Maggi und 29 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, AORN Sant'Anna e San Sebastiano, 81100 Caserta, Italy. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV Infections. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Doravirine (DOR) is a newly approved non-nucleoside reverse transcriptase inhibitor (NNRTI). We aimed to investigate, in a real-life setting, how switching to a DOR-based regimen rather than a rilpivirine (RPV)-based regimen impacted metabolic and hepatic safety. The analysis included 551 antiretroviral treatment (ART)-experienced people living with HIV (PLWH), starting RPV-based or DOR-based regimens with viral load < 200 copies/mL, baseline (T0), and at least one control visit (6-month visit, T1). We enrolled 295 PLWH in the RPV and 256 in the DOR cohort. At T1, total cholesterol (TC), low-density lipoprotein-C (LDL-C), and triglycerides significantly decreased in both DOR and RPV cohorts, while high-density lipoprotein-C (HDL-C) only decreased in RPV-treated people. Consistently, the TC/HDL-C ratio declined more markedly in the DOR (−0.36, p < 0.0001) than in the RPV cohort (−0.08, p = 0.25) (comparison p = 0.39). Similar trends were observed when excluding the PLWH on lipid-lowering treatment from the analysis. People with normal alanine aminotransferase (ALT) levels showed a slight ALT increase in both cohorts, and those with baseline ALT > 40 IU/L experienced a significant decline (−14 IU/L, p = 0.008) only in the DOR cohort. Lipid profile improved in both cohorts, and there was a significant reduction in ALT in PLWH with higher-than-normal baseline levels on DOR-based ART.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Unit, AORN Sant'Anna e San Sebastiano, 81100 Caserta, Italy.
- Fondazione ASIA Onlus, 20090 Buccinasco, Italy.
- AOU Infectious and Tropical Diseases, Careggi Hospital, 50134 Florence, Italy.
- Unit of Infectious Diseases, Santa Maria Hospital,06156 Perugia, Italy.
- Infectious Diseases Unit, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
- Unit of Infectious Diseases, A. Manzoni Hospital, 23900 Lecco, Italy.
ORCID-Profile: Paolo Maggi, Elena Delfina Ricci, Giuseppe Vittorio De Socio, Nicola Squillace, Chiara Molteni, Benedetto Maurizio Celesia, Giordano Madeddu, Giovanni Francesco Pellicanò, Antonio Cascio, Andrea Parisini, Stefano Rusconi, Salvatore Martini, Katia Falasca, Antonio Di Biagio, Paolo Bonfanti
Zitieren
APA
Maggi, P., Ricci, E. D., Martinelli, C. V., De Socio, G. V., Squillace, N., Molteni, C., Masiello, A., Orofino, G., Menzaghi, B., Bellagamba, R., Vichi, F., Celesia, B. M., Madeddu, G., Pellicanò, G. F., Carleo, M. A., Cascio, A., Parisini, A., Taramasso, L., Valsecchi, L., …, & CISAI Study Group (2023). Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting. Viruses, 15(7), 1612. https://doi.org/10.3390/v15071612
Vancouver
Maggi P, Ricci ED, Martinelli CV, De Socio GV, Squillace N, Molteni C, et al. Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting. Viruses. 2023;15(7):1612. doi:10.3390/v15071612
BibTeX
@article{Maggi2023,
author = {Maggi, Paolo and Ricci, Elena Delfina and Martinelli, Canio Vito and De Socio, Giuseppe Vittorio and Squillace, Nicola and Molteni, Chiara and Masiello, Addolorata and Orofino, Giancarlo and Menzaghi, Barbara and Bellagamba, Rita and Vichi, Francesca and Celesia, Benedetto Maurizio and Madeddu, Giordano and Pellicanò, Giovanni Francesco and Carleo, Maria Aurora and Cascio, Antonio and Parisini, Andrea and Taramasso, Lucia and Valsecchi, Laura and Calza, Leonardo and Rusconi, Stefano and Sarchi, Eleonora and Martini, Salvatore and Bargiacchi, Olivia and Falasca, Katia and Cenderello, Giovanni and Ferrara, Sergio and Di Biagio, Antonio and Bonfanti, Paolo and CISAI Study Group, CISAI Study Group},
title = {Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting},
journal = {Viruses},
year = {2023},
volume = {15},
number = {7},
pages = {1612},
doi = {10.3390/v15071612}
}
EUVIMED